A. Legrand

2.0k total citations
60 papers, 1.6k citations indexed

About

A. Legrand is a scholar working on Molecular Biology, Clinical Biochemistry and Surgery. According to data from OpenAlex, A. Legrand has authored 60 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 11 papers in Clinical Biochemistry and 9 papers in Surgery. Recurrent topics in A. Legrand's work include Metabolism and Genetic Disorders (8 papers), Mitochondrial Function and Pathology (6 papers) and Free Radicals and Antioxidants (6 papers). A. Legrand is often cited by papers focused on Metabolism and Genetic Disorders (8 papers), Mitochondrial Function and Pathology (6 papers) and Free Radicals and Antioxidants (6 papers). A. Legrand collaborates with scholars based in France, United States and Finland. A. Legrand's co-authors include Jacqueline Peynet, Patrice Thérond, Dominique Bonnefont‐Rousselot, M Gardès-Albert, Gwenolé Loas, D. Jore, Bernard Jégou, P Boyer, Jean‐Louis Beaudeux and J Delattre and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Gastroenterology and American Journal of Clinical Nutrition.

In The Last Decade

A. Legrand

59 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Legrand France 24 593 243 240 226 179 60 1.6k
Joachim Greilberger Austria 23 485 0.8× 137 0.6× 108 0.5× 266 1.2× 160 0.9× 76 1.7k
Hülya Aksoy Türkiye 21 227 0.4× 191 0.8× 87 0.4× 169 0.7× 116 0.6× 71 1.4k
İlker Durak Türkiye 28 351 0.6× 110 0.5× 84 0.3× 178 0.8× 73 0.4× 73 2.1k
Laura Mazzanti Italy 24 375 0.6× 88 0.4× 93 0.4× 138 0.6× 165 0.9× 73 1.5k
Susana Rovira‐Llopis Spain 28 971 1.6× 160 0.7× 199 0.8× 286 1.3× 425 2.4× 61 2.3k
Seval Aydın Türkiye 29 391 0.7× 242 1.0× 136 0.6× 374 1.7× 166 0.9× 90 2.2k
Zhaofeng Zhang China 31 839 1.4× 133 0.5× 76 0.3× 168 0.7× 331 1.8× 124 2.5k
Adel R. A. Abd‐Allah Egypt 25 583 1.0× 248 1.0× 75 0.3× 97 0.4× 88 0.5× 63 1.7k
Turgut Topal Türkiye 27 536 0.9× 111 0.5× 58 0.2× 379 1.7× 220 1.2× 83 2.3k

Countries citing papers authored by A. Legrand

Since Specialization
Citations

This map shows the geographic impact of A. Legrand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Legrand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Legrand more than expected).

Fields of papers citing papers by A. Legrand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Legrand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Legrand. The network helps show where A. Legrand may publish in the future.

Co-authorship network of co-authors of A. Legrand

This figure shows the co-authorship network connecting the top 25 collaborators of A. Legrand. A scholar is included among the top collaborators of A. Legrand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Legrand. A. Legrand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Albert, O, Christèle Lethimonier, Laurianne Lesné, et al.. (2013). Paracetamol, aspirin and indomethacin display endocrine disrupting properties in the adult human testis in vitro. Human Reproduction. 28(7). 1890–1898. 118 indexed citations
2.
Bonnefont‐Rousselot, Dominique, Noëlle Vignat, Jacqueline Peynet, et al.. (2006). Oxidative stress implication in a new phenotype of amyotrophic quadricipital syndrome with cardiac involvement due to lamin A/C mutation. Free Radical Research. 41(4). 424–431. 14 indexed citations
3.
Peynet, Jacqueline, et al.. (2006). Metformin reduces angiotensin-mediated intracellular production of reactive oxygen species in endothelial cells through the inhibition of protein kinase C. Biochemical Pharmacology. 72(2). 176–183. 53 indexed citations
4.
Slama, Abdelhamid, C. Lacroix, Violaine Planté‐Bordeneuve, et al.. (2005). Thymidine phosphorylase gene mutations in patients with mitochondrial neurogastrointestinal encephalomyopathy syndrome. Molecular Genetics and Metabolism. 84(4). 326–331. 34 indexed citations
5.
Brivet, M., et al.. (2005). First characterization of a large deletion of the PDHA1 gene. Molecular Genetics and Metabolism. 86(4). 456–461. 14 indexed citations
6.
Collin, Fabrice, et al.. (2004). Radical‐induced oxidation of metformin. European Journal of Biochemistry. 271(23-24). 4745–4752. 49 indexed citations
7.
Collin, Fabrice, Helen J. Khoury, Dominique Bonnefont‐Rousselot, et al.. (2004). Liquid chromatographic/electrospray ionization mass spectrometric identification of the oxidation end‐products of metformin in aqueous solutions. Journal of Mass Spectrometry. 39(8). 890–902. 34 indexed citations
8.
Beaudeux, Jean‐Louis, Ewa Ninio, Jeannette Soria, et al.. (2004). Activation of PAF receptor by oxidised LDL in human monocytes stimulates chemokine releases but not urokinase-type plasminogen activator expression. Clinica Chimica Acta. 344(1-2). 163–171. 11 indexed citations
9.
Costa, Carlos A. Bana e, José Manuel Correia da Costa, Abdelhamid Slama, et al.. (2003). Mutational spectrum and DNA-based prenatal diagnosis in carnitine–acylcarnitine translocase deficiency. Molecular Genetics and Metabolism. 78(1). 68–73. 23 indexed citations
10.
Bonnefont‐Rousselot, Dominique, Stéphane Walrand, M Gardès-Albert, et al.. (2003). An intracellular modulation of free radical production could contribute to the beneficial effects of metformin towards oxidative stress. Metabolism. 52(5). 586–589. 148 indexed citations
11.
Eschwège, Pascal, S. Droupy, Marc Conti, et al.. (2002). Value of lipid peroxidation by-products detected during the renal procurement on renal graft function. Transplantation Proceedings. 34(7). 2840–2840. 1 indexed citations
12.
Bonnefont‐Rousselot, Dominique, Patrice Thérond, Jean‐Louis Beaudeux, et al.. (2001). [Aging and oxidative stress. Which potential markers?].. PubMed. 59(4). 453–9. 15 indexed citations
13.
Loas, Gwenolé, et al.. (2000). Is Anhedonia a Specific Dimension in Chronic Schizophrenia?. Schizophrenia Bulletin. 26(2). 495–506. 26 indexed citations
14.
Loas, Gwenolé, P Boyer, & A. Legrand. (1999). Anhedonia in the Deficit Syndrome of Schizophrenia. Psychopathology. 32(4). 207–219. 20 indexed citations
15.
Martin‐Chouly, Corinne, et al.. (1999). In Vitro Evaluation of Vascular Permeability to Contrast Media Using Cultured Endothelial Cell Monolayers. Investigative Radiology. 34(11). 663–663. 8 indexed citations
16.
Eschwège, Pascal, Valérie Paradis, Marc Conti, et al.. (1998). Bcl-2 and Bax expression on rat ischemic kidney. Transplantation Proceedings. 30(6). 2861–2862. 5 indexed citations
17.
Raimond, Jacques, Drazen B. Zimonjic, C. Mignon, et al.. (1997). Mapping of the galectin-3 gene (LGALS3) to human Chromosome 14 at region 14q21-22. Mammalian Genome. 8(9). 706–707. 54 indexed citations
18.
Loas, Gwenolé, et al.. (1996). Anhedonia and negative symptomatology in chronic schizophrenia. Comprehensive Psychiatry. 37(1). 5–11. 25 indexed citations
19.
Davit–Spraul, Anne, V. Atger, Michèle Cambillau, et al.. (1996). Abnormal lipoprotein pattern in patients with Alagille syndrome depends on Icterus severity. Gastroenterology. 111(4). 1023–1032. 31 indexed citations
20.
Gaillard, O, D. Meillet, Annie Gervais, et al.. (1995). A Sensitive Time-Resolved Immunofluorometric Assay for the Measurement of Apolipoprotein B in Cerebrospinal Fluid. Application to Multiple Sclerosis and Other Neurological Diseases. Clinical Chemistry and Laboratory Medicine (CCLM). 33(1). 53–58. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026